{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:21:47Z","timestamp":1789608107457,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23316-0","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:05:43Z","timestamp":1768795543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A rat model of Immunologic and hypertensive kidney injury"],"prefix":"10.1038","volume":"16","author":[{"given":"Seo-Kyoung","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kodihalli C.","family":"Ravindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Lanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Coskran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"23316_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"GBDCKD Collaboration","year":"2020","unstructured":"Collaboration, G. B. D. C. K. D. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 395, 709\u2013733. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3 (2020).","journal-title":"Lancet"},{"key":"23316_CR2","doi-asserted-by":"publisher","first-page":"100438","DOI":"10.1016\/j.lanepe.2022.100438","volume":"20","author":"J Sundstrom","year":"2022","unstructured":"Sundstrom, J. et al. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2.4 million patients from 11 countries: the careme CKD study. Lancet Reg. Health Eur. 20, 100438. https:\/\/doi.org\/10.1016\/j.lanepe.2022.100438 (2022).","journal-title":"Lancet Reg. Health Eur."},{"key":"23316_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11906-008-0009-y","volume":"10","author":"YM Barri","year":"2008","unstructured":"Barri, Y. M. Hypertension and kidney disease: a deadly connection. Curr. Hypertens. Rep. 10, 39\u201345. https:\/\/doi.org\/10.1007\/s11906-008-0009-y (2008).","journal-title":"Curr. Hypertens. Rep."},{"key":"23316_CR4","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh, J. et al. Prevalence of chronic kidney disease in the united States. JAMA 298, 2038\u20132047. https:\/\/doi.org\/10.1001\/jama.298.17.2038 (2007).","journal-title":"JAMA"},{"key":"23316_CR5","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1111\/j.1523-1755.2005.00774.x","volume":"68","author":"M El Nahas","year":"2005","unstructured":"El Nahas, M. The global challenge of chronic kidney disease. Kidney Int. 68, 2918\u20132929. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00774.x (2005).","journal-title":"Kidney Int."},{"key":"23316_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/HYPERTENSIONAHA.117.08314","volume":"70","author":"KA Griffin","year":"2017","unstructured":"Griffin, K. A. Hypertensive kidney injury and the progression of chronic kidney disease. Hypertension 70, 687\u2013694. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.08314 (2017).","journal-title":"Hypertension"},{"key":"23316_CR7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2353\/ajpath.2006.050634","volume":"168","author":"K Doi","year":"2006","unstructured":"Doi, K. et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am. J. Pathol. 168, 1413\u20131424. https:\/\/doi.org\/10.2353\/ajpath.2006.050634 (2006).","journal-title":"Am. J. Pathol."},{"key":"23316_CR8","doi-asserted-by":"publisher","first-page":"F192","DOI":"10.1152\/ajprenal.00146.2006","volume":"292","author":"A Erdely","year":"2007","unstructured":"Erdely, A., Freshour, G., Tain, Y. L., Engels, K. & Baylis, C. DOCA\/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains. Am. J. Physiol-Renal. 292, F192\u2013F196. https:\/\/doi.org\/10.1152\/ajprenal.00146.2006 (2007).","journal-title":"Am. J. Physiol-Renal"},{"key":"23316_CR9","doi-asserted-by":"publisher","unstructured":"Liang, J. Q. & Liu, Y. H. Animal models of kidney disease: challenges and perspectives. Kidney360 4, 1479\u20131493. https:\/\/doi.org\/10.34067\/Kid.0000000000000227 (2023).","DOI":"10.34067\/Kid.0000000000000227"},{"key":"23316_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3181\/00379727-100-24736","volume":"100","author":"W Heymann","year":"1959","unstructured":"Heymann, W., Hackel, D. B., Harwood, S., Wilson, S. G. & Hunter, J. L. Production of nephrotic syndrome in rats by freund\u2019s adjuvants and rat kidney suspensions. Proc. Soc. Exp. Biol. Med. 100, 660\u2013664. https:\/\/doi.org\/10.3181\/00379727-100-24736 (1959).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"23316_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1681\/ASN.2004121098","volume":"16","author":"M Nangaku","year":"2005","unstructured":"Nangaku, M., Shankland, S. J. & Couser, W. G. Cellular response to injury in membranous nephropathy. J. Am. Soc. Nephrol. 16, 1195\u20131204. https:\/\/doi.org\/10.1681\/ASN.2004121098 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"23316_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1161\/01.hyp.20.3.298","volume":"20","author":"MO Ribeiro","year":"1992","unstructured":"Ribeiro, M. O., Antunes, E., de Nucci, G., Lovisolo, S. M. & Zatz, R. Chronic Inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20, 298\u2013303. https:\/\/doi.org\/10.1161\/01.hyp.20.3.298 (1992).","journal-title":"Hypertension"},{"key":"23316_CR13","doi-asserted-by":"publisher","first-page":"F697","DOI":"10.1152\/ajprenal.1994.266.5.F697","volume":"266","author":"CK Fujihara","year":"1994","unstructured":"Fujihara, C. K., Michellazzo, S. M., de Nucci, G. & Zatz, R. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO Inhibition. Am. J. Physiol. 266, F697\u2013705. https:\/\/doi.org\/10.1152\/ajprenal.1994.266.5.F697 (1994).","journal-title":"Am. J. Physiol."},{"key":"23316_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1161\/01.hyp.37.1.170","volume":"37","author":"CK Fujihara","year":"2001","unstructured":"Fujihara, C. K., Costa Malheiros, A., de Lourdes Noronha, D. M., De Nucci, I. I., Zatz, R. & G. & Mycophenolate mofetil reduces renal injury in the chronic nitric oxide synthase Inhibition model. Hypertension 37, 170\u2013175. https:\/\/doi.org\/10.1161\/01.hyp.37.1.170 (2001).","journal-title":"Hypertension"},{"key":"23316_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1053\/j.ackd.2005.07.011","volume":"12","author":"AA Eddy","year":"2005","unstructured":"Eddy, A. A. Progression in chronic kidney disease. Adv. Chronic Kidney Dis. 12, 353\u2013365. https:\/\/doi.org\/10.1053\/j.ackd.2005.07.011 (2005).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"23316_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1681\/ASN.2016060666","volume":"28","author":"L Tonneijck","year":"2017","unstructured":"Tonneijck, L. et al. Glomerular hyperfiltration in diabetes: Mechanisms, clinical Significance, and treatment. J. Am. Soc. Nephrol. 28, 1023\u20131039. https:\/\/doi.org\/10.1681\/ASN.2016060666 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"23316_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1053\/j.akdh.2022.12.003","volume":"30","author":"S Savedchuk","year":"2023","unstructured":"Savedchuk, S., Phachu, D., Shankar, M., Sparks, M. A. & Harrison-Bernard, L. M. Targeting glomerular hemodynamics for kidney protection. Adv. Kidney Dis. Health. 30, 71\u201384. https:\/\/doi.org\/10.1053\/j.akdh.2022.12.003 (2023).","journal-title":"Adv. Kidney Dis. Health"},{"key":"23316_CR18","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00424.2007","volume":"294","author":"C Baylis","year":"2008","unstructured":"Baylis, C. Nitric oxide deficiency in chronic kidney disease. Am. J. Physiol. Ren. Physiol. 294, F1\u20139. https:\/\/doi.org\/10.1152\/ajprenal.00424.2007 (2008).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"23316_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000189294","volume":"74","author":"N Uhlenius","year":"1996","unstructured":"Uhlenius, N. et al. Chronic Inhibition of nitric oxide synthase in Heymann nephritis. Nephron 74, 144\u2013149. https:\/\/doi.org\/10.1159\/000189294 (1996).","journal-title":"Nephron"},{"key":"23316_CR20","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrneph.2010.152","volume":"7","author":"T Nakagawa","year":"2011","unstructured":"Nakagawa, T. et al. Endothelial dysfunction as a potential contributor in diabetic nephropathy. Nat. Rev. Nephrol. 7, 36\u201344. https:\/\/doi.org\/10.1038\/nrneph.2010.152 (2011).","journal-title":"Nat. Rev. Nephrol."},{"key":"23316_CR21","doi-asserted-by":"publisher","unstructured":"Takahashi, T. & Harris, R. C. Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice. J Diabetes Res 590541, (2014). https:\/\/doi.org\/10.1155\/2014\/590541 (2014).","DOI":"10.1155\/2014\/590541"},{"key":"23316_CR22","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/ndt\/gfv063","volume":"30","author":"M Papasotiriou","year":"2015","unstructured":"Papasotiriou, M. et al. Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases. Nephrol. Dial Transpl. 30, 1112\u20131121. https:\/\/doi.org\/10.1093\/ndt\/gfv063 (2015).","journal-title":"Nephrol. Dial Transpl."},{"key":"23316_CR23","doi-asserted-by":"publisher","unstructured":"Hijmans, R. S. et al. Urinary collagen degradation products as early markers of progressive renal fibrosis. J. Transl Med. 15 https:\/\/doi.org\/10.1186\/s12967-017-1163-2 (2017).","DOI":"10.1186\/s12967-017-1163-2"},{"key":"23316_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.ackd.2016.11.002","volume":"24","author":"BM Klinkhammer","year":"2017","unstructured":"Klinkhammer, B. M., Goldschmeding, R., Floege, J. & Boor, P. Treatment of renal Fibrosis-Turning challenges into opportunities. Adv. Chronic Kidney Dis. 24, 117\u2013129. https:\/\/doi.org\/10.1053\/j.ackd.2016.11.002 (2017).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"23316_CR25","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.kint.2016.06.042","volume":"90","author":"JM Correas","year":"2016","unstructured":"Correas, J. M. et al. Ultrasound-based imaging methods of the kidney-recent developments. Kidney Int. 90, 1199\u20131210. https:\/\/doi.org\/10.1016\/j.kint.2016.06.042 (2016).","journal-title":"Kidney Int."},{"key":"23316_CR26","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/ajt.13180","volume":"15","author":"P Boor","year":"2015","unstructured":"Boor, P. & Floege, J. Renal allograft fibrosis: biology and therapeutic targets. Am. J. Transpl. 15, 863\u2013886. https:\/\/doi.org\/10.1111\/ajt.13180 (2015).","journal-title":"Am. J. Transpl."},{"key":"23316_CR27","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.kint.2021.04.032","volume":"100","author":"A Caroli","year":"2021","unstructured":"Caroli, A., Remuzzi, A. & Lerman, L. O. Basic principles and new advances in kidney imaging. Kidney Int. 100, 1001\u20131011. https:\/\/doi.org\/10.1016\/j.kint.2021.04.032 (2021).","journal-title":"Kidney Int."},{"key":"23316_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.addr.2017.10.013","volume":"121","author":"M Baues","year":"2017","unstructured":"Baues, M. et al. Fibrosis imaging: current concepts and future directions. Adv. Drug Deliv Rev. 121, 9\u201326. https:\/\/doi.org\/10.1016\/j.addr.2017.10.013 (2017).","journal-title":"Adv. Drug Deliv Rev."},{"key":"23316_CR29","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/ilar\/ilw019","volume":"57","author":"BR Campbell","year":"2016","unstructured":"Campbell, B. R. et al. In vivo imaging in pharmaceutical development and its impact on the 3Rs. ILAR J. 57, 212\u2013220. https:\/\/doi.org\/10.1093\/ilar\/ilw019 (2016).","journal-title":"ILAR J."},{"key":"23316_CR30","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ajpath.2019.12.009","volume":"190","author":"A Pisarek-Horowitz","year":"2020","unstructured":"Pisarek-Horowitz, A. et al. Loss of roundabout guidance receptor 2 (Robo2) in podocytes protects adult mice from glomerular injury by maintaining podocyte foot process structure. Am. J. Pathol. 190, 799\u2013816. https:\/\/doi.org\/10.1016\/j.ajpath.2019.12.009 (2020).","journal-title":"Am. J. Pathol."},{"key":"23316_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.15557\/JoU.2016.0013","volume":"16","author":"A Nowicki","year":"2016","unstructured":"Nowicki, A. & Dobruch-Sobczak, K. Introduction to ultrasound elastography. J. Ultrason. 16, 113\u2013124. https:\/\/doi.org\/10.15557\/JoU.2016.0013 (2016).","journal-title":"J. Ultrason."},{"key":"23316_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.diii.2013.01.022","volume":"94","author":"JL Gennisson","year":"2013","unstructured":"Gennisson, J. L., Deffieux, T., Fink, M. & Tanter, M. Ultrasound elastography: principles and techniques. Diagn. Interv Imaging. 94, 487\u2013495. https:\/\/doi.org\/10.1016\/j.diii.2013.01.022 (2013).","journal-title":"Diagn. Interv Imaging"},{"key":"23316_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods. 14, 417\u2013419. https:\/\/doi.org\/10.1038\/nmeth.4197 (2017).","journal-title":"Nat. Methods"},{"key":"23316_CR34","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy, D. J., Chen, Y. & Smyth, G. K. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 40, 4288\u20134297. https:\/\/doi.org\/10.1093\/nar\/gks042 (2012).","journal-title":"Nucleic Acids Res."},{"key":"23316_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. EdgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616 (2010).","journal-title":"Bioinformatics"},{"key":"23316_CR36","unstructured":"National Research Council: Guide for the care and use of laboratory animals, 8th edition, Washington DC: the National Academies Press (. ). (2011)."},{"key":"23316_CR37","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1111\/jcmm.17340","volume":"26","author":"S Park","year":"2022","unstructured":"Park, S. et al. RNA-seq profiling of tubulointerstitial tissue reveals a potential therapeutic role of dual anti-phosphatase 1 in glomerulonephritis. J. Cell. Mol. Med. 26, 3364\u20133377. https:\/\/doi.org\/10.1111\/jcmm.17340 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"23316_CR38","doi-asserted-by":"publisher","unstructured":"Nakagawa, S. et al. Molecular markers of tubulointerstitial fibrosis and tubular cell damage in patients with chronic kidney disease. Plos One. 10 https:\/\/doi.org\/10.1371\/journal.pone.0136994 (2015). doi:ARTN e0136994.","DOI":"10.1371\/journal.pone.0136994"},{"key":"23316_CR39","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","volume":"18","author":"XW Song","year":"2009","unstructured":"Song, X. W. et al. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum. Mol. Genet. 18, 2328\u20132343. https:\/\/doi.org\/10.1093\/hmg\/ddp165 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"23316_CR40","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","volume":"619","author":"BB Lake","year":"2023","unstructured":"Lake, B. B. et al. An atlas of healthy and injured cell States and niches in the human kidney. Nature 619, 585\u2013. https:\/\/doi.org\/10.1038\/s41586-023-05769-3 (2023).","journal-title":"Nature"},{"key":"23316_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ddmod.2010.11.001","volume":"7","author":"JA Jefferson","year":"2010","unstructured":"Jefferson, J. A., Pippin, J. W. & Shankland, S. J. Experimental models of membranous nephropathy. Drug Discov Today Dis. Models. 7, 27\u201333 (2010).","journal-title":"Drug Discov Today Dis. Models"},{"key":"23316_CR42","first-page":"17","volume":"72","author":"I Narita","year":"1995","unstructured":"Narita, I., Border, W. A., Ketteler, M. & Noble, N. A. Nitric oxide mediates Immunologic injury to kidney Mesangium in experimental glomerulonephritis. Lab. Invest. 72, 17\u201324 (1995).","journal-title":"Lab. Invest."},{"key":"23316_CR43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1172\/JCI115849","volume":"90","author":"C Baylis","year":"1992","unstructured":"Baylis, C., Mitruka, B. & Deng, A. Chronic Blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 90, 278\u2013281. https:\/\/doi.org\/10.1172\/JCI115849 (1992).","journal-title":"J. Clin. Invest."},{"key":"23316_CR44","doi-asserted-by":"publisher","first-page":"R469","DOI":"10.1152\/ajpregu.1996.270.2.R469","volume":"270","author":"GR Guarasci","year":"1996","unstructured":"Guarasci, G. R. & Kline, R. L. Pressure natriuresis following acute and chronic Inhibition of nitric oxide synthase in rats. Am. J. Physiol. 270, R469\u2013478. https:\/\/doi.org\/10.1152\/ajpregu.1996.270.2.R469 (1996).","journal-title":"Am. J. Physiol."},{"key":"23316_CR45","doi-asserted-by":"publisher","first-page":"R991","DOI":"10.1152\/ajpregu.00207.2005","volume":"289","author":"DL Mattson","year":"2005","unstructured":"Mattson, D. L. & Meister, C. J. Renal cortical and medullary blood flow responses to L-NAME and ANG II in wild-type, nNOS null mutant, and eNOS null mutant mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R991\u2013997. https:\/\/doi.org\/10.1152\/ajpregu.00207.2005 (2005).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"23316_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-981-13-8871-2_13","volume":"1165","author":"XM Meng","year":"2019","unstructured":"Meng, X. M., Mak, T. S. & Lan, H. Y. Macrophages in renal fibrosis. Adv. Exp. Med. Biol. 1165, 285\u2013303. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_13 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"23316_CR47","first-page":"915","volume":"144","author":"R Pichler","year":"1994","unstructured":"Pichler, R. et al. Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). Am. J. Pathol. 144, 915\u2013926 (1994).","journal-title":"Am. J. Pathol."},{"key":"23316_CR48","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1053\/ajkd.2000.9790","volume":"36","author":"H Okada","year":"2000","unstructured":"Okada, H. et al. Tubular osteopontin expression in human glomerulonephritis and renal vasculitis. Am. J. Kidney Dis. 36, 498\u2013506. https:\/\/doi.org\/10.1053\/ajkd.2000.9790 (2000).","journal-title":"Am. J. Kidney Dis."},{"key":"23316_CR49","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1046\/j.1523-1755.2001.00032.x","volume":"60","author":"Y Xie","year":"2001","unstructured":"Xie, Y. et al. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int. 60, 1645\u20131657. https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00032.x (2001).","journal-title":"Kidney Int."},{"key":"23316_CR50","doi-asserted-by":"publisher","first-page":"F556","DOI":"10.1152\/ajprenal.1998.274.3.F556","volume":"274","author":"JP Valentin","year":"1998","unstructured":"Valentin, J. P., Ying, W. Z., Couser, W. G. & Humphreys, M. H. Extrarenal resistance to atrial natriuretic peptide in rats with experimental nephrotic syndrome. Am. J. Physiol-Renal. 274, F556\u2013F563. https:\/\/doi.org\/10.1152\/ajprenal.1998.274.3.F556 (1998).","journal-title":"Am. J. Physiol-Renal"},{"key":"23316_CR51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/s0140-6736(68)90589-8","volume":"2","author":"RA Risdon","year":"1968","unstructured":"Risdon, R. A., Sloper, J. C. & De Wardener, H. E. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2, 363\u2013366. https:\/\/doi.org\/10.1016\/s0140-6736(68)90589-8 (1968).","journal-title":"Lancet"},{"key":"23316_CR52","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1681\/ASN.V7122495","volume":"7","author":"AA Eddy","year":"1996","unstructured":"Eddy, A. A. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol. 7, 2495\u20132508. https:\/\/doi.org\/10.1681\/ASN.V7122495 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"23316_CR53","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/ki.1993.312","volume":"44","author":"AK Sharma","year":"1993","unstructured":"Sharma, A. K., Mauer, S. M., Kim, Y. & Michael, A. F. Interstitial fibrosis in obstructive nephropathy. Kidney Int. 44, 774\u2013788. https:\/\/doi.org\/10.1038\/ki.1993.312 (1993).","journal-title":"Kidney Int."},{"key":"23316_CR54","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00330-011-2229-9","volume":"22","author":"M Derieppe","year":"2012","unstructured":"Derieppe, M. et al. Detection of intrarenal microstructural changes with supersonic shear wave elastography in rats. Eur. Radiol. 22, 243\u2013250. https:\/\/doi.org\/10.1007\/s00330-011-2229-9 (2012).","journal-title":"Eur. Radiol."},{"key":"23316_CR55","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ncb826","volume":"4","author":"JG Abreu","year":"2002","unstructured":"Abreu, J. G., Ketpura, N. I., Reversade, B. & De Robertis, E. M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell. Biol. 4, 599\u2013604. https:\/\/doi.org\/10.1038\/ncb826 (2002).","journal-title":"Nat. Cell. Biol."},{"key":"23316_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2353\/ajpath.2008.070057","volume":"172","author":"Y Li","year":"2008","unstructured":"Li, Y. et al. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am. J. Pathol. 172, 299\u2013308. https:\/\/doi.org\/10.2353\/ajpath.2008.070057 (2008).","journal-title":"Am. J. Pathol."},{"key":"23316_CR57","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.kint.2016.01.030","volume":"89","author":"CH Lin","year":"2016","unstructured":"Lin, C. H. et al. Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney. Kidney Int. 89, 1281\u20131292. https:\/\/doi.org\/10.1016\/j.kint.2016.01.030 (2016).","journal-title":"Kidney Int."},{"key":"23316_CR58","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.bbadis.2015.04.014","volume":"1852","author":"S Brings","year":"2015","unstructured":"Brings, S. et al. Diabetes-induced alterations in tissue collagen and carboxymethyllysine in rat kidneys: association with increased collagen-degrading proteinases and amelioration by Cu(II)-selective chelation. Biochim. Biophys. Acta. 1852, 1610\u20131618. https:\/\/doi.org\/10.1016\/j.bbadis.2015.04.014 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"23316_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-1536-7-4","volume":"7","author":"F Genovese","year":"2014","unstructured":"Genovese, F., Manresa, A. A., Leeming, D. J., Karsdal, M. A. & Boor, P. The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? Fibrogenesis Tissue Repair. 7, 4. https:\/\/doi.org\/10.1186\/1755-1536-7-4 (2014).","journal-title":"Fibrogenesis Tissue Repair."},{"key":"23316_CR60","doi-asserted-by":"publisher","unstructured":"Frak, W. et al. Role of uremic Toxins, oxidative Stress, and renal fibrosis in chronic kidney disease. Antioxid. (Basel). 13. https:\/\/doi.org\/10.3390\/antiox13060687 (2024).","DOI":"10.3390\/antiox13060687"},{"key":"23316_CR61","doi-asserted-by":"publisher","first-page":"155913","DOI":"10.1016\/j.metabol.2024.155913","volume":"155","author":"X Zhao","year":"2024","unstructured":"Zhao, X. et al. Role of mitochondria in pathogenesis and therapy of renal fibrosis. Metabolism 155, 155913. https:\/\/doi.org\/10.1016\/j.metabol.2024.155913 (2024).","journal-title":"Metabolism"},{"key":"23316_CR62","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/jcb.30195","volume":"123","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Diabetic kidney disease-predisposing Proinflammatory and profibrotic genes identified by weighted gene co-expression network analysis (WGCNA). J. Cell. Biochem. 123, 481\u2013492. https:\/\/doi.org\/10.1002\/jcb.30195 (2022).","journal-title":"J. Cell. Biochem."},{"key":"23316_CR63","doi-asserted-by":"publisher","first-page":"1183088","DOI":"10.3389\/fimmu.2023.1183088","volume":"14","author":"Y Guo","year":"2023","unstructured":"Guo, Y., Cen, K., Hong, K., Mai, Y. & Jiang, M. Construction of a neural network diagnostic model for renal fibrosis and investigation of immune infiltration characteristics. Front. Immunol. 14, 1183088. https:\/\/doi.org\/10.3389\/fimmu.2023.1183088 (2023).","journal-title":"Front. Immunol."},{"key":"23316_CR64","doi-asserted-by":"publisher","unstructured":"Fang, Y. et al. miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1. Oxid Med Cell Longev 4708516, (2017). https:\/\/doi.org\/10.1155\/2017\/4708516 (2017).","DOI":"10.1155\/2017\/4708516"},{"key":"23316_CR65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/0886022X.2021.1901739","volume":"43","author":"HY Ma","year":"2021","unstructured":"Ma, H. Y., Chen, S. & Du, Y. Estrogen and Estrogen receptors in kidney diseases. Ren. Fail. 43, 619\u2013642. https:\/\/doi.org\/10.1080\/0886022X.2021.1901739 (2021).","journal-title":"Ren. Fail."},{"key":"23316_CR66","doi-asserted-by":"publisher","unstructured":"Basting, T. & Lazartigues, E. DOCA-Salt hypertension: an update. Curr. Hypertens. Rep. 19 https:\/\/doi.org\/10.1007\/s11906-017-0731-4 (2017). doi:ARTN.","DOI":"10.1007\/s11906-017-0731-4"},{"key":"23316_CR67","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0039-128x(96)00010-4","volume":"61","author":"EP Gomez-Sanchez","year":"1996","unstructured":"Gomez-Sanchez, E. P., Zhou, M. & Gomez-Sanchez, C. E. Mineralocorticoids, salt and high blood pressure. Steroids 61, 184\u2013188. https:\/\/doi.org\/10.1016\/0039-128x(96)00010-4 (1996).","journal-title":"Steroids"},{"key":"23316_CR68","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1081\/jdi-100100882","volume":"22","author":"SP Tofovic","year":"2000","unstructured":"Tofovic, S. P., Kusaka, H., Kost, C. K. Jr. & Bastacky, S. Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats. Ren. Fail. 22, 387\u2013406. https:\/\/doi.org\/10.1081\/jdi-100100882 (2000).","journal-title":"Ren. Fail."},{"key":"23316_CR69","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1523-1755.1998.00019.x","volume":"54","author":"DJ Kelly","year":"1998","unstructured":"Kelly, D. J., Wilkinson-Berka, J. L., Allen, T. J., Cooper, M. E. & Skinner, S. L. A new model of diabetic nephropathy with progressive renal impairment in the Transgenic (mRen-2)27 rat (TGR). Kidney Int. 54, 343\u2013352. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00019.x (1998).","journal-title":"Kidney Int."},{"key":"23316_CR70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ki.2008.507","volume":"75","author":"H Ikeda","year":"2009","unstructured":"Ikeda, H. et al. Spironolactone suppresses inflammation and prevents L-NAME-induced renal injury in rats. Kidney Int. 75, 147\u2013155. https:\/\/doi.org\/10.1038\/ki.2008.507 (2009).","journal-title":"Kidney Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23316-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23316-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23316-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:13:34Z","timestamp":1769213614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23316-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["23316"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23316-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"22 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2415"}}